IBEX Limited
NASDAQ:IBEX · NASDAQ Global Market
-$0.52 today
Vol 0.23M · Avg 0.12M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $36.9M +9.5% | $33.7M +6.6% | $31.6M +47.2% | $21.5M +63.9% | $13.1M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $17.2M -11.5% | $19.5M +2.5% | $19.0M +4.9% | $18.1M +28.2% | $14.1M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | -$2.9M -936.3% | $344.0K -92.4% | $4.5M +187.6% | -$5.2M -170.1% | -$1.9M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $5.4M +44.3% | $3.8M -18.3% | $4.6M +148.8% | $1.9M -65.5% | $5.4M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | -$26.3M +29.4% | -$37.3M -10.7% | -$33.7M -199.0% | -$11.3M +58.2% | -$27.0M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$19.3M | $0 +100.0% | -$12.3M -26.7% | -$9.7M +27.2% | -$13.3M | $592.6M | $1.3B | $626.2M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $6.2M +378.2% | -$2.2M +40.2% | -$3.8M -262.7% | $2.3M +157.5% | -$4.0M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | -$13.3M +62.1% | -$35.0M -98.6% | -$17.6M -355.9% | -$3.9M +59.9% | -$9.6M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $15.3M -4.0% | $16.0M +0.7% | $15.8M +5.4% | $15.0M +21.2% | $12.4M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $45.7M +27.2% | $35.9M -14.2% | $41.9M +4.6% | $40.0M +148.8% | $16.1M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$18.4M -107.5% | -$8.9M +53.3% | -$19.0M +26.9% | -$25.9M -24.5% | -$20.8M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $0 | $0 +100.0% | -$85.0K | $0 | $0 | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$18.4M -107.5% | -$8.9M +53.5% | -$19.0M +26.6% | -$25.9M -24.5% | -$20.8M | $4.8B | $6.4B | $5.1B |
| Debt Repayment | -$953.0K -75.5% | -$543.0K +96.5% | -$15.4M +18.0% | -$18.8M -9.3% | -$17.2M | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $0 | $0 | $0 | $0 -100.0% | $63.1M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | -$78.0M -261.9% | -$21.6M -7710.1% | -$276.0K +91.9% | -$3.4M | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 +100.0% | -$4.0M | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | $4.3M +1076.8% | $366.0K -82.2% | $2.1M +5765.7% | $35.0K +103.3% | -$1.0M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | -$74.7M -243.5% | -$21.7M -59.6% | -$13.6M +38.5% | -$22.1M -154.1% | $40.9M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | -$3.0K +85.7% | -$21.0K +96.6% | -$610.0K +36.8% | -$965.0K -433.1% | -$181.0K | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | -$47.4M -995.3% | $5.3M -38.5% | $8.6M +195.4% | -$9.0M -125.1% | $36.0M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | $27.3M +0.9% | $27.0M +18.1% | $22.9M +62.6% | $14.1M +396.8% | -$4.7M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector

OneSpan Inc.
NASDAQ:OSPN
$499.00M
Climb Global Solutions, Inc.
NASDAQ:CLMB
$409.70M

Xerox Holdings Corporation
NASDAQ:XRX
$402.19M

TSS, Inc.
NASDAQ:TSSI
$373.35M

Telos Corporation
NASDAQ:TLS
$324.34M

The Hackett Group, Inc.
NASDAQ:HCKT
$256.18M

Conduent Incorporated
NASDAQ:CNDT
$223.34M

Endava plc
NYSE:DAVA
$143.31M
NovaBridge Biosciences
NASDAQ:NBP
$74.17M
LZ Technology Holdings Limited Class B Ordinary Shares
LZMH
$11.23M
SEC Filings
Recent regulatory filings
No filings found.
Does IBEX generate free cash flow?
IBEX Limited (IBEX) generated $27.29M of free cash flow in fiscal 2025.
How much operating cash flow does IBEX produce?
Operating cash flow was $45.67M, before capital expenditures of $18.38M.
Explore More
Continue the stock analysis
Jump to another research area for this company.